These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17986743)

  • 41. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R; Solomon H; Contis J; Kaminski D
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monoethylglycinexylidide (MEGX)-test. A test for the assessment of prognosis before and after liver transplantation].
    Reichel C; Wienkoop G; Nacke A; Spengler U
    Dtsch Med Wochenschr; 1995 Feb; 120(6):179-83. PubMed ID: 7851289
    [No Abstract]   [Full Text] [Related]  

  • 43. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score.
    Gindro T; Arrigoni A; Martinasso G; Rosina F; Perardi S; Cappello N; Benedetti P; Actis GC; Verme G; Rizzetto M
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1155-9. PubMed ID: 9471020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection.
    Lorf T; Schnitzbauer AA; Schaefers SK; Scherer MN; Schlitt HJ; Oellerich M; Becker H; Obed A
    Hepatogastroenterology; 2008; 55(82-83):539-43. PubMed ID: 18613404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients.
    Conti F; Dousset B; Cherruau B; Guérin C; Soubrane O; Houssin D; Calmus Y
    Clin Transplant; 2004 Jun; 18(3):235-41. PubMed ID: 15142042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoethylglycinexylide formation in assessing pediatric donor liver function.
    Rossi SJ; Schroeder TJ; Vine WH; A-Kader HH; Gremse DA; Ryckman FC; Pedersen SH; Pesce AJ; Balistreri WF
    Ther Drug Monit; 1992 Dec; 14(6):452-6. PubMed ID: 1485364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.
    Zhang HC; Hu RF; Zhu T; Tong L; Zhang QQ
    World J Gastroenterol; 2016 Jun; 22(22):5276-84. PubMed ID: 27298571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive liver functional impairment is associated with an increase in AST/ALT ratio.
    Giannini E; Botta F; Fasoli A; Ceppa P; Risso D; Lantieri PB; Celle G; Testa R
    Dig Dis Sci; 1999 Jun; 44(6):1249-53. PubMed ID: 10389705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.
    Shiffman ML; Luketic VA; Sanyal AJ; Duckworth PF; Purdum PP; Contos MJ; Mills AS; Edinboro LE; Poklis A
    Hepatology; 1994 Apr; 19(4):933-40. PubMed ID: 8138268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?
    Testa R; Valente U; Risso D; Caglieris S; Giannini E; Fasoli A; Botta F; Dardano G; Lantieri PB; Celle G
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):559-63. PubMed ID: 10755262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Importance of determination of monoethylglycinexylidide (MEGX)--as a liver function test in hepatology and liver transplantation].
    Kupcová V
    Bratisl Lek Listy; 1999 Jan; 100(1):49-53. PubMed ID: 10492998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following trauma.
    Pea F; Licari M; Baldassarre M; Furlanut M
    Fundam Clin Pharmacol; 2002 Dec; 16(6):519-25. PubMed ID: 12685511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM; Hickman PE; Lynch SV; Henderson A; Wright M; Balderson G; Strong RW
    Transplantation; 1993 Dec; 56(6):1385-8. PubMed ID: 8279008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lidocaine elimination and MEGX formation after oral lidocaine administration--a practicable test for assessment of quantitative liver function].
    Klinker H; Joeres R; Bomhard M; Keller F; Dorer J; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():52-5. PubMed ID: 7483715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score.
    Oellerich M; Hartmann H; Ringe B; Burdelski M; Lautz HU; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1116-9. PubMed ID: 8442062
    [No Abstract]   [Full Text] [Related]  

  • 58. The clinical importance of conventional and quantitative liver function tests in liver transplantation.
    Tanaka E; Inomata S; Yasuhara H
    J Clin Pharm Ther; 2000 Dec; 25(6):411-9. PubMed ID: 11123494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
    Lancet; 1989 Mar; 1(8639):640-2. PubMed ID: 2564460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure.
    Lehmann U; Armstrong VW; Schütz E; Regel G; Pape D; Oellerich M
    Ther Drug Monit; 1995 Apr; 17(2):125-32. PubMed ID: 7624899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.